Connor, Clark & Lunn Investment Management Ltd. Danaher Corp Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $26 Billion
  • Q2 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Danaher Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 48,680 shares of DHR stock, worth $9.76 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
48,680
Previous 126,822 61.62%
Holding current value
$9.76 Million
Previous $26 Million 63.01%
% of portfolio
0.04%
Previous 0.12%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$174.64 - $205.16 $13.6 Million - $16 Million
-78,142 Reduced 61.62%
48,680 $9.62 Million
Q1 2025

May 12, 2025
BUY
$201.62 - $250.59 $18.7 Million - $23.2 Million
92,643 Added 271.05%
126,822 $26 Million
Q4 2024

Feb 10, 2025
SELL
$226.16 - $274.52 $14 Million - $16.9 Million
-61,689 Reduced 64.35%
34,179 $7.85 Million
Q3 2024

Nov 08, 2024
SELL
$239.25 - $280.76 $9.25 Million - $10.9 Million
-38,672 Reduced 28.74%
95,868 $26.7 Million
Q2 2024

Aug 09, 2024
SELL
$235.51 - $267.98 $14.9 Million - $16.9 Million
-63,179 Reduced 31.95%
134,540 $33.6 Million
Q1 2024

May 09, 2024
BUY
$224.58 - $256.19 $39.3 Million - $44.9 Million
175,183 Added 777.35%
197,719 $49.4 Million
Q4 2023

Feb 09, 2024
BUY
$185.1 - $233.13 $4.17 Million - $5.25 Million
22,536 New
22,536 $5.21 Million
Q2 2023

Aug 10, 2023
SELL
$224.99 - $256.14 $46.9 Million - $53.3 Million
-208,266 Reduced 56.61%
159,646 $38.3 Million
Q1 2023

May 09, 2023
BUY
$239.75 - $277.0 $57.7 Million - $66.7 Million
240,765 Added 189.36%
367,912 $92.7 Million
Q4 2022

Feb 10, 2023
BUY
$241.42 - $282.29 $30.5 Million - $35.7 Million
126,363 Added 16117.73%
127,147 $33.8 Million
Q3 2022

Nov 10, 2022
BUY
$247.06 - $1507.4 $193,695 - $1.18 Million
784 New
784 $202,000
Q2 2022

Aug 05, 2022
SELL
$237.11 - $299.66 $14.7 Million - $18.6 Million
-62,125 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$257.27 - $315.76 $409,059 - $502,058
1,590 Added 2.63%
62,125 $18.2 Million
Q4 2021

Feb 10, 2022
BUY
$292.08 - $329.01 $3.38 Million - $3.8 Million
11,561 Added 23.61%
60,535 $19.9 Million
Q3 2021

Nov 12, 2021
SELL
$272.21 - $332.43 $42 Million - $51.3 Million
-154,461 Reduced 75.93%
48,974 $14.9 Million
Q2 2021

Aug 12, 2021
SELL
$225.08 - $271.69 $11.2 Million - $13.6 Million
-49,971 Reduced 19.72%
203,435 $54.6 Million
Q1 2021

May 13, 2021
SELL
$212.38 - $245.9 $6.79 Million - $7.86 Million
-31,951 Reduced 11.2%
253,406 $57 Million
Q4 2020

Feb 16, 2021
BUY
$212.5 - $245.46 $30.8 Million - $35.6 Million
145,166 Added 103.55%
285,357 $63.4 Million
Q3 2020

Nov 12, 2020
BUY
$177.16 - $215.33 $12.5 Million - $15.2 Million
70,528 Added 101.24%
140,191 $30.2 Million
Q2 2020

Aug 13, 2020
BUY
$128.7 - $176.83 $4.11 Million - $5.65 Million
31,963 Added 84.78%
69,663 $12.3 Million
Q4 2019

Feb 12, 2020
BUY
$133.47 - $153.48 $5.03 Million - $5.79 Million
37,700 New
37,700 $5.79 Million
Q3 2018

Nov 13, 2018
SELL
$98.13 - $108.9 $17.6 Million - $19.5 Million
-179,325 Closed
0 $0
Q2 2018

Aug 02, 2018
SELL
$96.1 - $103.24 $16.9 Million - $18.1 Million
-175,675 Reduced 49.49%
179,325 $17.7 Million
Q1 2018

May 14, 2018
BUY
$92.16 - $103.8 $511,488 - $576,090
5,550 Added 1.59%
355,000 $34.8 Million
Q4 2017

Feb 09, 2018
SELL
$85.26 - $94.62 $6.31 Million - $7 Million
-73,975 Reduced 17.47%
349,450 $32.4 Million
Q3 2017

Nov 14, 2017
BUY
$79.29 - $88.45 $15.1 Million - $16.9 Million
190,875 Added 82.08%
423,425 $36.3 Million
Q2 2017

Aug 14, 2017
BUY
N/A
232,550
232,550 $19.6 Million

Others Institutions Holding DHR

# of Institutions
2,496
Shares Held
562M
Call Options Held
7.02M
Put Options Held
3.36M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $146B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email